Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension

NCT01952925 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01952925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01952925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2019
Completion date
March 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

afib, hypertension